Publications by authors named "Nigel S Moore"

Claim this Profile
I
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.
Adrian D Hobson, Russell A Judge, Ana L Aguirre, Brian S Brown, Yifang Cui, Nigel S Moore

J Med Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.
Adrian D Hobson, Christopher M Harris, Elizabeth L van der Kam, Sean C Turner, Ayome Abibi, Nigel S Moore

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
Maria A Argiriadi, Eric R Goedken, David Banach, David W Borhani, Andrew Burchat, Nigel St John Moore

BMC Struct Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
Patrick Betschmann, Brian Bettencourt, Diana Donnelly-Roberts, Michael Friedman, Jonathan George, Nigel Stjohn Moore

Bioorg Med Chem Lett· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis